bit.ly
Congress: Protect Patients and Hold Hospitals Accountable for Exploiting 340B
The 340B program was meant to give vulnerable patients affordable access to medicine. Instead, hospitals are abusing it, buying...
#340B is an active hashtag on Bluesky. In the last 30 days, 7 people shared 25 posts with it — around 1 a day. Activity is down 17% versus the previous week, peaking on Jul 14 with 4 posts.
Tags most often used together with #340B.
bit.ly
Congress: Protect Patients and Hold Hospitals Accountable for Exploiting 340B
The 340B program was meant to give vulnerable patients affordable access to medicine. Instead, hospitals are abusing it, buying...
statnews.com
Pharmalittle: We're reading about Moderna's flu shot, a death in a gene-editing trial in China, and more
In today's Pharmalittle newsletter: Moderna's mRNA flu shot approved, a death reported in a gene-editing trial in China, and more.
adapadvocacyassociation.blogspot.com
Medical Debt Soars, Despite 340B Purchases Passing $100 Billion
By: Marcus J. Hopkins , Health Policy Lead Consultant, ADAP Advocacy Drug purchases under the 340B Drug Pricing Program exceeded $100 billio...
drugch.nl
How a Company Makes Millions Off a Hospital Program Meant to Help the Poor (Gift Article)
A private business has helped supercharge a controversial federal drug program. Patients and insurers have been left with big bills.
buff.ly
Don't play politics in protecting access to affordable medications | Opinion
A bill submitted by three lawmakers bars insurers and pharmacy benefit managers from discriminating against a provider because it participates in the 340B program.
adapadvocacyassociation.blogspot.com
Medical Debt Soars, Despite 340B Purchases Passing $100 Billion
By: Marcus J. Hopkins , Health Policy Lead Consultant, ADAP Advocacy Drug purchases under the 340B Drug Pricing Program exceeded $100 billio...
drugch.nl
Insulin Prices Dropped. But Some Poor Patients Are Paying More.
A law that coaxed companies to lower the price of drugs came with a little-known consequence: smaller discounts for low-income health clinics.
statnews.com
Pharmalittle: We're reading about a cancer therapy's gold rush, FDA warning Sanofi, and more news
A Belgian court dismissed a lawsuit against EU chief Ursula von der Leyen centered on text messages she exchanged with Pfizer's CEO during negotiations for Covid shots.
adapadvocacyassociation.blogspot.com
Medical Debt Soars, Despite 340B Purchases Passing $100 Billion
By: Marcus J. Hopkins , Health Policy Lead Consultant, ADAP Advocacy Drug purchases under the 340B Drug Pricing Program exceeded $100 billio...
statnews.com
Pharmalittle: We're reading about Moderna's flu shot, a death in a gene-editing trial in China, and more
In today's Pharmalittle newsletter: Moderna's mRNA flu shot approved, a death reported in a gene-editing trial in China, and more.
adapadvocacyassociation.blogspot.com
Medical Debt Soars, Despite 340B Purchases Passing $100 Billion
By: Marcus J. Hopkins , Health Policy Lead Consultant, ADAP Advocacy Drug purchases under the 340B Drug Pricing Program exceeded $100 billio...
statnews.com
Pharmalittle: We're reading about AstraZeneca-Bristol merger talks, a revised 340B plan, and more
AstraZeneca stock fell as investors balked at reports of merger talks with Bristol Myers Squibb about forming one of the world's biggest drugmakers
adapadvocacyassociation.blogspot.com
Medical Debt Soars, Despite 340B Purchases Passing $100 Billion
By: Marcus J. Hopkins , Health Policy Lead Consultant, ADAP Advocacy Drug purchases under the 340B Drug Pricing Program exceeded $100 billio...
statnews.com
Trump administration revises rebate pilot for 340B drug discount program, angering hospitals
The Trump administration is revising its rebate pilot for the 340B drug discount program, angering hospitals.
news.bloomberglaw.com
HHS Revises Rebate Pilot for Hospital Drug Discount Program (1)
The US Department of Health and Human Services issued a revised pilot that will soon require certain healthcare providers to purchase medicines through a rebate system, significantly shifting how they...
statnews.com
Pharmalittle: We're reading about a fugitive who became a biotech exec, a hospital suing Lilly, and more
The discovery that a fugitive had been working under an alias in the biotech industry prompted a question: How did he evade scrutiny for two decades?
statnews.com
Pharmalittle: We're reading about FDA views on a Duchenne drug, GSK cost savings, and more
The FDA said a Capricor stem cell treatment for Duchenne muscular dystrophy did not meet a Phase 3 trial's objectives — contrary to company claims
statnews.com
Pharmalittle: We're reading about Lilly obesity drug data, a push for FDA to ban DTC ads, and more
A study of Lilly's retatrutide weight loss drug in people with heart disease did not answer a crucial question — whether it reduces cardiovascular risk
Posts are pulled live from Bluesky and cached briefly. Posts with content labels are hidden.